FDA Import Refusal SCS-1342033-8/11/1 — Glaxosmithkline
The FDA refused shipment SCS-1342033-8/11/1 from Glaxosmithkline (United Kingdom) on Jul 27, 2020. The refused product falls under Drugs and Biologics — ANTI-VIRAL N.E.C.. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jul 27, 2020
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 62VDJ99 ANTI-VIRAL N.E.C.
- Charges
- 75